Efficacy of oral treatment with BV-araU against cutaneous infection with herpes simplex type 1 in shaved mice
- 29 February 1992
- journal article
- research article
- Published by Elsevier in Antiviral Research
- Vol. 17 (2) , 133-143
- https://doi.org/10.1016/0166-3542(92)90047-9
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Effect of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil against herpes simplex virus type 1 infection in immunosuppressed miceAntimicrobial Agents and Chemotherapy, 1990
- Comparison of antiviral efficacies of 1-β-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil (brovavir) and acyclovir against herpes simplex virus type 1 infections in miceAntiviral Research, 1990
- Effect of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil (brovavir) on experimental infections in mice with herpes simplex virus type 1 strains of different degrees of virulenceAntimicrobial Agents and Chemotherapy, 1990
- Antiherpes activity of the immunomodulator OK-432, a streptococcal preparation, in immunosuppressed miceAntiviral Research, 1988
- Comparison of susceptibilities of varicella-zoster virus and herpes simplex viruses to nucleoside analogsAntimicrobial Agents and Chemotherapy, 1986
- Topical treatment of cutaneous herpes simplex virus infection in hairless mice with (E)-5-(2-bromovinyl)-2'-deoxyuridine and related compoundsAntimicrobial Agents and Chemotherapy, 1984
- In vitro and in vivo antiviral activity of 1-β-d-arabinofuranosyl-E-5-(2-bromovinyl)uracil (BV-araU) and related compoundsAntiviral Research, 1984
- Antiherpesviral and anticellular effects of 1-beta-D-arabinofuranosyl-E-5-(2-halogenovinyl) uracilsAntimicrobial Agents and Chemotherapy, 1981
- Mechanism of Acquired Resistance to Herpes Simplex Virus Infection as Studied in Nude MiceJournal of General Virology, 1979